BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Mar 15, 2026; 18(3): 116567
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.116567
Table 6 Receiver operating characteristic performance (hepatocellular carcinoma vs cirrhosis)
Biomarker
AUC (bootstrap 95%CI)
Optimal cutoff
Sensitivity (%)
Specificity (%)
hsa-miR-21-5p0.990 (0.974-1.000)> 14.098.696.7
hsa-miR-155-5p0.874 (0.809-0.930)> 3.875.793.3
LAIR-1+ T cell %0.833 (0.767-0.895)> 55.952.9100.0
LAIR-1 MFI0.997 (0.990-1.000)> 29.3100.098.3


Write to the Help Desk